Fantastic paper attempting to bring two Groups of Cirrhosis Leadership together — Baveno / EFCLIF.. portal hypertension meets systemic inflammation. Must say this is an amazing paper. Looking forward to your thoughts…

Pathomechanistic #Phenotypes of #Cirrhosis Dalila Costa🇵🇹 Jonel Trebicka🇩🇪 Cristina Ripoll🇪🇸 Richard Moreau🇫🇷 @rajivjalan.bsky.social🇬🇧 Reiberger🇦🇹 📈 Portal Hypertension #PH & 🔥 Inflammation #SI coexist in pts w/ cirrhosis 💡review on PH-SI interplay in distinct cirrhosis stages @easlnews.bsky.social

Our @GeorgKRAMER myself & @CristinaRIPOLL perspective on staging of #Decompensated #Cirrhosis - this was a Letter ✉️ to @jhepatology.bsky.social in response to an article by Dr. Verma @rajivjalan.bsky.social et al #NonAcuteDecompensation (NAD) 🔗 t.ly/mc4VG - who responded w/ an interesting proposal

Feel free to follow the new A-TANGO Consortium + #hepatology Starter Pack go.bsky.app/Tc8YSWq #LiverSky #LiverResearch #LiverDisease #hepatitis #cirrhosis #ACLF #HepatologyJournals @rajivjalan.bsky.social @europeliver.bsky.social @easlnews.bsky.social @jhepatology.bsky.social @ebtapper.bsky.social

High ammonia levels kill liver cells by damaging their mitochondria, but this can be prevented using an existing drug due to start clinical trials, finds a new study in mice led by Prof Rajiv Jalan @rajivjalan.bsky.social from UCL Division of Medicine www.ucl.ac.uk/news/2025/ma...

🚨 New Insights in Cirrhosis! 🚨 www.journal-of-hepatology.eu/article/S016... Our study reveals Non-Acute Decompensation (NAD) is a distinct clinical state, different from compensated cirrhosis & acute decompensation (AD) @rajivjalan.bsky.social @jhepatology.bsky.social @akashroyy.bsky.social

Please share your views about whether the PSVD nomenclature is the way forward or an oversimplification. Personally, I think it is an advance but hugely respect the view of #Lohse, #Sarin and #Kamath

Fascinating discussion on PSVD, NCPF, Idiopathic portal hypertension ongoing in @jhepatology.bsky.social @valdig.bsky.social @ebtapper.bsky.social would be worth a skytutorial

Fascinating discussion on PSVD, NCPF, Idiopathic portal hypertension ongoing in @jhepatology.bsky.social @valdig.bsky.social @ebtapper.bsky.social would be worth a skytutorial

Hello! I’m here to celebrate all you and your colleagues do for us patients! Yay!! Welcome!!

Thanks for following Elliot… good to be here and getting out of X

#liversky Rajiv is here @rajivjalan.bsky.social

Hello, Liver People on Blue SKy… migrating from X…#liver twitter, @uclnews.bsky.social